Osiris Therapeutics
Latest round
- Series E
Last raised
- Oct 1996
Total raised
- $10M
Investors
- 1
About Osiris Therapeutics
Osiris Therapeutics, Inc.Osiris Therapeutics, Inc. is a biotechnology company specializing in regenerative medicine. Founded in 1992 in Columbia, Maryland, US, it has completed 12 deals, with its most recent deal occurring on August 7, 2006. The company underwent a pivotal acquisition by Smith & Nephew plc in March 2019 for approximately USD 660 mn.com. The core offering revolves around facilitating the sale or lease of domain names, providing owners with an efficient avenue to monetize their digital assets. The primary end-use case addresses the demand for high-value domain names, enabling businesses to establish credibility and improve visibility in the digital landscape.In 2018, Osiris Therapeutics, Inc.73 mn.Following its recent acquisition, Osiris Therapeutics, Inc. is expected to leverage Smith & Nephew’s extensive global network to enhance its product offerings and expand into new markets. This strategy aims to position Osiris Therapeutics favorably in the evolving biotechnology landscape.
Who invested in Osiris Therapeutics
1 investor across 1 round
See all investors in Osiris Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Oct 16, 1996
Amount
$10M
Investors
Questions about Osiris Therapeutics
Who invested in Osiris Therapeutics?
Osiris Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Osiris Therapeutics raised?
Osiris Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Osiris Therapeutics last raise money?
Osiris Therapeutics's most recent round on record is a Series E, in Oct 1996.
What does Osiris Therapeutics do?
Osiris Therapeutics is a pharmaceuticals company.
Where is Osiris Therapeutics headquartered?
Osiris Therapeutics is headquartered in Columbia, US.
Which VCs invest in companies like Osiris Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Osiris Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Osiris Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.